| Trial phase |
Antenatal screening |
Antenatal Enrolment and Baseline |
Randomisation |
6 w old follow-up |
6 m old follow-up |
1 y old follow-up |
18 m old follow-up |
2 y old follow-up |
End Phase 1 |
2.5 y old follow-up |
3 y old follow-up |
3.5 y old follow-up |
4 y old follow-up |
4.5 y old follow-up |
5 y old follow-up |
5.5 y old follow-up |
First year of school follow-up (5-6 y old) |
6 y old follow-up |
*COVID-19 Supplement (6-7 y old) |
End Phase 2 |
| Year |
2013-2014 |
2013-2014 |
2013-2014 |
2013-2014 |
2013-2015 |
2014-2015 |
2014-2016 |
2015-2016 |
|
2015-2017 |
2016-2017 |
2016-2018 |
2017-2018 |
2017-2019 |
2018-2019 |
2018-2020 |
2019-2021 |
2019-2020 |
2020 |
|
| Medications (general) |
|
S:FPS 1 |
|
|
|
S:FPS 1 |
S:FPS 1 2 |
S:FPS 1 |
|
|
S:FPS 1 |
|
S:FPS 1 |
|
S:FPS 1 |
|
|
S:FPS 1 |
|
|
| Supplements (general) |
|
S:FPS 1 |
|
|
|
S:FPS 1 |
S:FPS 1 2 |
S:FPS 1 |
|
|
S:FPS 1 |
|
S:FPS 1 |
|
S:FPS 1 |
|
|
S:FPS 1 |
|
|
Featured measurements
FPS: Family Psychosocial Screening derived
Notes
1 8 items from the Family Psychosocial Screening questionnaire were used, including a general drug/medications question
2 Completed at 18 months if not completed at 1 year visit
Legend
| A |
= Administration report abstraction |
| C |
= Index child report (reporting on others) |
| L |
= Linkage (to other databases) |
| M |
= Medical records data abstraction |
| O |
= Observation/direct assessment |
| N |
= Nurse report |
| P |
= Parent/primary caregiver report |
| Pe |
= Peer report |
| S |
= Self report |
| T |
= Teacher report |
| X |
= Undefined |
| X BF |
= Pertaining to biological father |
| X BM |
= Pertaining to biological mother |
| X C |
= Pertaining to index child |
| X F |
= Pertaining to father |
| X Fam |
= Pertaining to family |
| X G |
= Pertaining to grandparent(s) |
| X M |
= Pertaining to mother |
| X P |
= Pertaining to parent(s) |
| X Pa |
= Pertaining to partner |
| X Pe |
= Pertaining to peers |
| X Pr |
= Pertaining to primary caregiver |
| X Si |
= Pertaining to sibling(s) |
